NCT07243587 Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
| NCT ID | NCT07243587 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique Tivoli Ducos |
| Condition | Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2021-02-01 |
| Primary Completion | 2036-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2021-02-01 with a primary completion date of 2036-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endometriosis is a chronic benign gynecological condition affecting 5 to 10% of women of reproductive age, often responsible for pelvic pain, digestive symptoms, and infertility, leading to a significant reduction in quality of life. Despite its high prevalence, the long-term outcomes of different medical and surgical treatments remain poorly documented. The IFEMENDO study is a prospective, observational, single-center, non-interventional cohort conducted at the Endometriosis Center of Clinique Tivoli-Ducos in Bordeaux, France. The objective is to evaluate the long-term efficacy of various therapeutic strategies-both medical and surgical-in terms of symptom improvement, quality of life, recurrence, and fertility outcomes. Women with histologically or radiologically confirmed pelvic endometriosis are invited to participate. Data are collected through standardized questionnaires at baseline and at 1, 3, 5, 7, and 10 years after inclusion, either via the secure NO ENDO online platform or in paper form. The study will contribute to a better understanding of the natural history of endometriosis and the long-term effectiveness of different treatment approaches, ultimately supporting improvements in clinical management and patient care.
Eligibility Criteria
Inclusion Criteria: * Women aged \>18 years * Women with histologically or radiologically confirmed deep endometriosis (and/or) infiltrating the colon and/or rectum * Women affiliated with the social security system Exclusion Criteria: * Refusal to participate * Patients under guardianship or curatorship, or deprived of liberty
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07243587 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07243587 currently recruiting?
Yes, NCT07243587 is actively recruiting participants. Contact the research team at horace.roman@ifemendo.fr for enrollment information.
Where is the NCT07243587 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT07243587 clinical trial?
NCT07243587 is sponsored by Clinique Tivoli Ducos. The trial plans to enroll 15,000 participants.